The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
申请公布号
CA2615022(C)
申请公布日期
2012.09.04
申请号
CA20062615022
申请日期
2006.07.14
申请人
MERCK & CO., INC.
发明人
HOLLOWAY, M. KATHARINE;LIVERTON, NIGEL J.;LUDMERER, STEVEN W.;MCCAULEY, JOHN A.;OLSEN, DAVID B.;RUDD, MICHAEL T.;VACCA, JOSEPH P.;MCINTYRE, CHARLES J.
